Esta Multi Usaha Tbk. vs Champion Pacific Indonesia Tbk. — how do they compare? Esta Multi Usaha Tbk. trades at Rp172 (market cap 424.44B, 1.98M 24h volume), while Champion Pacific Indonesia Tbk. trades at Rp416 (market cap 384.1B, 8.4K 24h volume). The key difference: Esta Multi Usaha Tbk. and Champion Pacific Indonesia Tbk. are close in size by market cap, and Esta Multi Usaha Tbk. is more actively traded (1.98M versus 8.4K). Which is the better fit depends on your goals.
| ESTA | IGAR | |
|---|---|---|
Market Cap | 424.44B | 384.1B |
Volume | 1.98M | 8.4K |
Lot | 19.8K | 84 |
Turnover | 342.89M | 3.49M |
Average Price | 173.17 | 415.95 |
Value | 342.89M | 3.49M |
Indicative Equilibrium Price | 172 | 414 |
Indicative Equilibrium Volume | 47 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Esta Multi Usaha Tbk (the “Company”) was established under the name PT Esta Asri Propertindo, based on Notarial Deed No. 34 dated September 30, 2011 of Kun Hidayat, S.H., notary in Jakarta. The Company started its commercial operations in 2012. Until 2017, the Company only did real estate leasing business activities. In 2018, the Company started its hospitality business activities.Whereas in 2019, the Company commenced vehicle rental business activities without option rights.
Read more on ESTA →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Read more on IGAR →